Mitralign Inc. logo — company profile

Mitralign Inc.

Founded 2003 United States Tewksbury, United States 2 employees Venture round Total: $174.97M Health Care, Medical Devices

General Information

Company Name Mitralign Inc.
Founded Year 2003
Location United States Tewksbury, United States
Employees 2
Industries Health Care, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Mitralign Inc.. To contact Mitralign Inc., visit mitralign.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Mitralign Inc. compare?

A PDF of Mitralign Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Mitralign Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Mitralign Inc.

Mitralign, Inc. is a **valve repair company** based near Boston, Massachusetts, USA, founded in **2003**. The company has received a substantial **$9.77M Venture Round investment on February 2, 2018**. Mitralign developed the **Mitralign Percutaneous Annuloplasty System (MPAS)**, a direct transcatheter annuloplasty system designed to address functional tricuspid regurgitation and mitral regurgitation. This innovative therapy targets the reduction of **functional mitral regurgitation (FMR), a life-threatening cardiac condition affecting four million people in the U.S. alone**. Their MPAS is intended for the treatment of symptomatic functional mitral regurgitation (MR ≥ 3+) for annular reduction through tissue plication. Additionally, the company has developed an approach to treating tricuspid valve regurgitation with a delivery system designed for transcatheter tricuspid valve repair. It's essential to note that the **Trialign System is an investigational device** and is limited by Federal (or United States) Law to investigational use only, therefore not available for sale or commercial distribution. The MPAS is also not commercially available in the U.S. **Mitralign** is positioned to provide a **lifeline for millions of patients** who have exhausted other therapeutic options.

Overall, Mitralign offers a promising solution for interventional cardiologists and their patients, addressing a critical unmet need in the treatment of mitral and tricuspid valve regurgitation. With their innovative technology and compelling market potential, the company presents an intriguing opportunity for venture capitalists seeking to invest in the health care industry.

Business keywords: Medical Innovation, Cardiac Technology, Mitral Valve Repair, Tricuspid Valve Repair, Percutaneous Treatment, Interventional Cardiology, Venture-backed, Catheter-based Technology, Functional Mitral Regurgitation, Transcatheter Annuloplasty, Investigational Device, Top Tier Venture Capitalists, Cardiovascular Device, Startup

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $9.77M -
02 Feb 2018
Series E $39.80M -
17 May 2016
Series E $23.00M 1
Qiming Venture Partners
01 Jan 2015
Venture Round $8.00M 1
Saints Capital
20 Jun 2014
Venture Round $1.90M 1
Orchestra Medical Ventures
26 Oct 2012
Debt Financing $7.00M -
11 Sep 2012
Series D $35.00M 6
Saints Capital, Forbion +4
16 May 2012
Series C $24.00M 8
Giza Venture Capital, Triathlon Medical Venture Partners +6
31 Dec 2007
Series B $13.00M 4
Giza Venture Capital, Accelerated Technologies Partners +2
30 Jun 2006
Series B $3.30M 1
Triathlon Medical Venture Partners
20 Apr 2006

View All 12 Funding Rounds

Mitralign Inc. Alternatives & Competitors

View All Alternatives
Mitralign Inc. vs

Advanced transcatheter therapy for resilient heart health and optimal blood flow

Venture round
11-50 employees
Health Care, Health and Wellness
Mitralign Inc. vs

Designing the future of cardiac valve repair through innovative non-surgical solutions.

Series D
Health Care, Manufacturing
Mitralign Inc. vs

Pioneering minimally invasive mitral valve repair solutions for effective heart disease treatment

Series D
1 employees
Health Care, Medical Devices

FAQ About Mitralign Inc.

Mitralign, Inc. is the valve repair company with the only direct transcatheter annuloplasty system designed to treat both functional tricuspid regurgitation and mitral regurgitation. We are a venture-backed, medical innovation company located near Boston, Massachusetts, USA. We’ve developed an inno...
Mitralign Inc. was founded in 2003.
Mitralign Inc. is headquartered in Tewksbury, United States.
Mitralign Inc. operates in Health Care and Medical Devices. Its work centres on Medical Innovation, Cardiac Technology, Mitral Valve Repair and Tricuspid Valve Repair.
Mitralign Inc. has approximately 2 employees.
Mitralign Inc. has completed 12 funding rounds, raising a total of $174.97M. The latest funding stage is Venture round.
Top alternatives and competitors to Mitralign Inc. include MVRx, Inc., Evalve, Hanyu Medical, Cardiac Dimensions, JenaValve Technology, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Mitralign Inc. and MVRx, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Mitralign Inc., https://bouncewatch.com/company/mitralign, updated 1 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes